Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma
NCT05508399
·
clinicaltrials.gov ↗
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Locally Advanced Gastric Adenocarcinoma
PD-1
Interventions
OTHER:
DNA panel and RNA Sequencing
Sponsor
Xijing Hospital